Two law firms that filed competing class actions against regenerative medicine company Mesoblast for allegedly misleading shareholders about its Remestemcel-L treatment for COVID-19 complications have agreed to join forces and sidestep a beauty parade.
Fair Work Ombudsman accuses barrister of underpaying paralegal
Hyundai, Kia face class action investigation over engine defect
Law firms’ agency agreement prevails over ‘opaque’ funding in Nuix class action battle
Blue Sky, auditor EY hit with shareholder class action
Murdoch sues Crikey for defamation over Trump ‘co-conspirator’ claim
Morrison faces inquiry over multiple ministries, as SG says appointments ‘undermined’ responsible government
Sister wins Darling Point round in Macarthur-Onslow family feud
Hall & Wilcox brings on new construction partner from boutique
Lawyers’ failure kept me from claiming privilege, says Mayfair’s Mawhinney
The founder of beleaguered investment group Mayfair 101, James Mawhinney, has argued that multiple law firms failed to advise him of the privilege against self-exposure to penalty in proceedings brought by the corporate regulator, which saw him banned from soliciting funds or promoting any financial product for 20 years.